Exact Sciences (EXAS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec1

Abbott Announces $21 Billion Acquisition of Alere to Enhance Diagnostic Business

00:16

Nov28

Abbott Acquires Exact Sciences for $21 Billion in Cash

10:11

Nov24

Jefferies Downgrades Exact Sciences Rating While Upgrading Price Target

13:59

Nov21

EXAS Shares Gap Up, Executives Sell Stocks

16:09

Nov20

Abbott Announces Acquisition of Precipio for Approximately $21 Billion

12:32

Nov10

Precision Sciences Obtains Exclusive License for Freenome Blood-based Colorectal Cancer Screening Test

12:24

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 850.74 M, Net Income -19.59 M, EPS -0.1035

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 811.09 M, Net Income -1.185 M, EPS -0.0062

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 706.79 M, Net Income -101.22 M, EPS -0.5417

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change